Find information on intracranial mass, including symptoms, diagnosis codes (ICD-10), clinical documentation improvement (CDI) best practices, and healthcare resources. Learn about brain tumor diagnosis, intracranial lesion management, neurology coding, and documentation guidelines for accurate medical billing and coding. Explore the latest research, treatment options, and support for patients diagnosed with an intracranial mass. This resource provides comprehensive information for healthcare professionals, coders, and patients seeking to understand intracranial masses.
Also known as
Benign neoplasm of brain
Non-cancerous tumors within the brain.
Malignant neoplasm of brain
Cancerous tumors originating within the brain.
Neoplasm of uncertain behavior
Brain tumors of unknown cancerous potential.
Other brain disorders
Catch-all code for intracranial masses not elsewhere classified.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the intracranial mass malignant?
When to use each related code
| Description |
|---|
| Intracranial Mass |
| Brain Tumor |
| Metastatic Brain Lesion |
Coding intracranial mass without specifying lobe, bone, or other location can lead to claim denials and inaccurate DRG assignment.
Discrepancy between documented histology and ICD-10 code can trigger audits and affect quality reporting and reimbursement.
Failure to document laterality (right, left, bilateral) for intracranial mass impacts coding accuracy and may cause claim rejection.
Patient presents with complaints suggestive of an intracranial mass. Symptoms include persistent headache, new-onset seizures, changes in vision (blurred vision, diplopia, visual field deficits), nausea, vomiting, balance problems, cognitive impairment (memory loss, confusion), personality changes, and weakness or numbness. Neurological examination may reveal focal neurological deficits, papilledema, or cranial nerve palsies. Differential diagnosis includes brain tumor (glioma, meningioma, metastasis), brain abscess, intracranial hemorrhage, cyst, and aneurysm. Imaging studies such as MRI brain with and without contrast, CT scan of the head, and or PET scan are indicated for diagnosis and characterization of the intracranial mass. Based on imaging findings, the intracranial mass measures [size] cm in diameter and is located in the [location] region of the brain. The mass appears [description of mass characteristics: e.g., well-circumscribed, heterogenous, enhancing]. Biopsy may be required for definitive diagnosis and histopathological analysis. Treatment options for intracranial mass include surgical resection, radiation therapy (stereotactic radiosurgery, whole-brain radiation), chemotherapy, and or targeted therapy depending on the type, location, and size of the mass. The patient's condition warrants neurosurgical consultation for further evaluation and management of the intracranial mass. ICD-10 codes may include D33.X (Benign neoplasm of brain and other parts of central nervous system), C71.X (Malignant neoplasm of brain), or D32.X (Benign neoplasm of spinal cord, cranial nerves, and other parts of central nervous system), depending on the final diagnosis. Medical billing and coding will reflect the complexity of the case and procedures performed. Continued monitoring and follow-up care are essential for optimal patient outcomes. Patient education regarding diagnosis, treatment options, potential complications, and prognosis will be provided.